Medical technology firm Riverain Technologies has received U.S. Food and Drug Administration clearance for a software program that compares current and prior chest X-ray images. Comparing differences between current and prior chest X-rays of the same patient will help draw clinicians’ attention to what may be an emerging or enlarging tumor, according to a statement […]
Riverain Technologies has received regulatory approval for the next-generation version of its imaging software that “suppresses” bones to help radiologists detect cancerous lung nodules. OnGuard 5.2, the latest version of the software, uses pattern recognition and machine learning technologies to essentially allow radiologists to see behind ribs and clavicles that often obscure lung abnormalities. OnGuard […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
With regulatory approval in hand, Riverain Medical is looking to boost sales of its imaging software that the company says can help radiologists better diagnose lung disease via its “bone suppression technology.” The Dayton, Ohio-area company last year received 510(k) clearance on two imaging software products and has thus far completed about 30 customer installations. […]